June 1, 2012 - GVS S.p.A, Bologna, Italy has acquired the filter product business from NP Medical Inc. The acquired products are manufactured in Cayey, Puerto Rico and are marketed under NP Medical's IVEX and Nutrivex brands.
NP Medical is a wholly owned subsidiary of Nypro Inc.. Both NP Medical Inc. and Nypro Inc. are headquartered in Clinton, Massachusetts USA.
Founded in 1979, GVS is a global technology leader in the development and manufacture of filtration products primarily serving the medical and automotive markets. GVS has eleven manufacturing plants in Italy, United Kingdom, Brazil, China, Romania and the United States, with supporting sales offices in fourteen countries.
"The acquisition of the IVEX and Nutrivex brands represents our continued global growth strategy focus in the healthcare market. Together with our existing line, SpeedFlow, the IVEX and Nutrivex business will allow our Group to become a world leader in the IV filter business in terms of quantity and range of products. We look forward to serving the NP customers who purchase the IVEX and Nutrivex brands." said Massimo Scagliarini, GVS CEO.
NP Medical Inc. designs, develops, manufactures and distributes proprietary intravenous (IV) drug and fluid delivery products used in a variety of critical medical applications such as chemotherapy and intensive care. Products are distributed to large medical device OEMs where NP Medical maintains a leading market position in the IV fluid control valve market.
"We have been very pleased to work with GVS. The sale of the filter business to a global filtration leader such as GVS allows NP Medical to focus on our continued growth in the high-performance IV valve and patient safety solutions space." said Luis J Maseda, General Manager, NP Medical.
CMC Consulting provided advisory services to GVS in support of this transaction.
For further information please contact:
GVS S.p.A. Corporate Press Office
or +39 051 6176338
NP Medical Inc. Corporate Communications
or +1 978-368-4580